Similar Search Results

Is There Evidence of a Real Estate Collateral Channel Effect on Listed Firm Investment in China?

Gyourko, Joseph; Deng, Yongheng; Wu, Jing - National Bureau of Economic Research (NBER) - 2013

Previous research on the United States and Japan finds economically large impacts of changing real estate collateral value on firm investment. Working with unique data on land values in 35 major Chinese markets and a panel of firms outside the real estate industry, we estimate investment...

Persistent link: https://www.econbiz.de/10010796599

Search for a Common Factor in Public and Private Real Estate Returns

Ang, Andrew; Nabar, Neil; Wald, Sam - National Bureau of Economic Research (NBER) - 2013

This paper is no longer available on-line from the NBER. A revised version of the paper has been published as "Searching for a Common Factor in Public and Private Real Estate Returns" in the Journal of Portfolio Management JPM RE 2013, Vol. 39, No. 5: pp. 120-133.

Persistent link: https://www.econbiz.de/10010821748

New cellular networks in Malawi: Correlates of service rollout and network performance

Thornton, Rebecca L.; Batzilis, Dimitrios; Dinkelman, Taryn - National Bureau of Economic Research (NBER) - 2010

Cellular technologies have become increasingly important in the developing world; infrastructure for mobile networks has expanded dramatically over the past two decades giving access to remote areas without previous phone service. Despite this expansion, relatively little is known about the...

Persistent link: https://www.econbiz.de/10008764662

The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity

Cockburn, Iain M.; Aitken, Murray L.; Berndt, Ernst R.; … - National Bureau of Economic Research (NBER) - 2013

We examine six molecules facing initial loss of US exclusivity (LOE, from patent expiration or challenges) between June 2009 and May 2013 that were among the 50 most prescribed molecules in May 2013. We examine prices per day of therapy (from the perspective of average revenue received by retail...

Persistent link: https://www.econbiz.de/10010969367

Defacto and Deeded Intellectual Property: Knowledge-Driven Co-Evolution of Firm Collaboration Boundaries and IPR Strategy

Zucker, Lynne; Darby, Michael R. - National Bureau of Economic Research (NBER) - 2014

provide substantial natural excludability reducing or preventing entry of imitators. …

Persistent link: https://www.econbiz.de/10010950753

Patents and the Global Diffusion of New Drugs

Cockburn, Iain M.; Lanjouw, Jean O.; Schankerman, Mark - National Bureau of Economic Research (NBER) - 2014

This paper studies how patent rights and price regulation affect how fast new drugs are launched in different countries, using newly constructed data on launches of 642 new drugs in 76 countries for the period 1983-2002, and information on the duration and content of patent and price control...

Persistent link: https://www.econbiz.de/10010950846

Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007

Conti, Rena M.; Berndt, Ernst R. - National Bureau of Economic Research (NBER) - 2014

estimated prices of these drug undergoing LOE fall with generic entry. Second, we estimate reduced form random effects models of … utilization subsequent to LOE. We observe substantial price erosion after generic entry; average monthly price declines appear to … entry, but this result appears to be largely driven by oral drugs. We discuss second-best welfare consequences of these …

Persistent link: https://www.econbiz.de/10010950850

Starving (or Fattening) the Golden Goose?: Generic Entry and the Incentives for Early-Stage Pharmaceutical Innovation

Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. - National Bureau of Economic Research (NBER) - 2014

Over the last decade, generic penetration in the U.S. pharmaceutical market has increased substantially, providing significant gains in consumer surplus. What impact has this rise in generic penetration had on the rate and direction of early stage pharmaceutical innovation? We explore this...

Persistent link: https://www.econbiz.de/10010951198

Price Indexes for Clinical Trial Research: A Feasibility Study

Cockburn, Iain M.; Berndt, Ernst R. - National Bureau of Economic Research (NBER) - 2013

We estimate hedonic price indexes for clinical trial research, an important component of biomedical R&D, using a large sample of agreements between trial sponsors and clinical investigators obtained from Medidata Solutions Worldwide Inc. Nominal prices measured as total grant cost per patient...

Persistent link: https://www.econbiz.de/10010951267

Direct to Consumer Advertising of Pharmaceutical Drugs: Information and Persuasion

Bar, Talia; Lillard, Dean R. - National Bureau of Economic Research (NBER) - 2014

We formally model direct to consumer advertising (DTCA) of prescription drugs and examine factors that determine a pharmaceutical firm's DTCA strategy. We highlight how the profitability of DTCA varies with the characteristics of the condition that the advertised drug treats, the incidence of...

Persistent link: https://www.econbiz.de/10010951290

1
2
3
4
5
6
7
8
9
10
Next
Last